Form 15-12G - Securities registration termination [Section 12(g)]
02 Dicembre 2024 - 2:39PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________
FORM 15
________________________
CERTIFICATION AND NOTICE OF TERMINATION
OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-40850
________________________
Exscientia plc
(Exact name
of registrant as specified in its charter)
________________________
The Schrödinger Building
Oxford Science Park
Oxford OX4 4GE
United Kingdom
Tel: +44 (0) 1865 818941
(Address, including
zip code, and telephone number, including area code, of registrant’s principal executive offices)
Ordinary Shares of Exscientia plc, nominal value
£0.0005 per share
(Title of each class
of securities covered by this Form)
None
(Titles of all other
classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
________________________
Please place an X in the box(es) to designate
the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) |
☒ |
| Rule 12g-4(a)(2) |
☐ |
| Rule 12h-3(b)(1)(i) |
☒ |
| Rule 12h-3(b)(1)(ii) |
☐ |
| Rule 15d-6 |
☐ |
| Rule 15d-22(b) |
☐ |
Approximate number of holders of record as
of the certification or notice date: 2*
*Pursuant to that certain
Transaction Agreement, dated as of August 8, 2024, as amended, by and between Exscientia plc, a public limited company incorporated under
the laws of England and Wales with registered number 13483814 (“Exscientia”) and Recursion
Pharmaceuticals, Inc., a Delaware corporation (“Recursion”), Recursion and a nominee acquired the entire issued
and to be issued share capital of Exscientia pursuant to a scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006
on November 20, 2024.
Pursuant to the requirements of the Securities
Exchange Act of 1934, Exscientia plc has caused this certification/notice to be signed and filed on its behalf by the undersigned duly
authorized person.
Date: December 2, 2024
| |
EXSCIENTIA PLC
|
| |
| By: |
/s/ Ben Taylor |
| Name: |
Ben Taylor |
| Title: |
Chief Financial Officer |
Grafico Azioni Exscientia (NASDAQ:EXAI)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Exscientia (NASDAQ:EXAI)
Storico
Da Dic 2023 a Dic 2024
